GALECTIN THERAPEUTICS INC (GALT)
About GALECTIN THERAPEUTICS INC
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$30.8M
- Total assets
- $19.5M
- Market cap
- $153.4M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $20.1M
- Operating income
- -$20.1M
- Income tax
- $0
- Net income
- -$30.8M
- EPS (basic)
- $-0.48
- EPS (diluted)
- $-0.48
Balance sheet
- Total assets
- $19.5M
- Current assets
- $19.4M
- Total liabilities
- $145.7M
- Current liabilities
- $8.0M
- Shareholders’ equity
- -$127.9M
Cash flow
- Operating cash flow
- -$23.9M
- Investing cash flow
- -$2.6M
- Financing cash flow
- $26.5M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $153.4M
- EPS (diluted)
- $-0.48
- Shares outstanding
- 44.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Sep 4, 2002
Galectin Therapeutics Inc (GALT) Stock Price
- Reported a net loss of $30.8M.
- Trading 47% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review GALECTIN THERAPEUTICS INC.
Write a review
News about GALECTIN THERAPEUTICS INC
News & sentiment via Polygon.io
Galectin Therapeutics Inc: frequently asked questions
Is Galectin Therapeutics Inc an American company?
Galectin Therapeutics Inc is a US-based company headquartered in Norcross, Georgia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Galectin Therapeutics Inc headquartered?
Galectin Therapeutics Inc is headquartered in Norcross, Georgia, United States.
Is Galectin Therapeutics Inc publicly traded?
Yes — Galectin Therapeutics Inc is a publicly traded company. Its stock trades under the ticker symbol GALT on the NASDAQ.
What does Galectin Therapeutics Inc do?
Galectin Therapeutics Inc is an American Pharmaceuticals company in the Health & Beauty sector.
